<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-08-12">August 12, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Yijie</forename><surname>Ding</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">School of Computer Science and Technology</orgName>
								<orgName type="institution">Tianjin University</orgName>
								<address>
									<postCode>300350</postCode>
									<settlement>Tianjin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Tianjin University Institute of Computational Biology</orgName>
								<address>
									<postCode>300350</postCode>
									<settlement>Tianjin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jijun</forename><surname>Tang</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">School of Computer Science and Technology</orgName>
								<orgName type="institution">Tianjin University</orgName>
								<address>
									<postCode>300350</postCode>
									<settlement>Tianjin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Tianjin University Institute of Computational Biology</orgName>
								<address>
									<postCode>300350</postCode>
									<settlement>Tianjin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Computer Science and Engineering</orgName>
								<orgName type="institution">University of South Carolina</orgName>
								<address>
									<postCode>29208</postCode>
									<settlement>Columbia</settlement>
									<region>SC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Fei</forename><surname>Guo</surname></persName>
							<email>fguo@tju.edu.cn</email>
							<affiliation key="aff3">
								<orgName type="department">School of Computer Science and Technology</orgName>
								<orgName type="institution">Tianjin University</orgName>
								<address>
									<postCode>300350</postCode>
									<settlement>Tianjin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Tianjin University Institute of Computational Biology</orgName>
								<address>
									<postCode>300350</postCode>
									<settlement>Tianjin</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Identification of Drug-Target Interactions via Multiple Information Integration Yijie Ding</orgName>
								<address>
									<settlement>Jijun Tang, Fei Guo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Information Sciences</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Identification of Drug-Target Interactions via Multiple Information Integration</orgName>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-08-12">August 12, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">E7045346CCDD4579FF33FC75F79AE24C</idno>
					<idno type="DOI">10.1016/j.ins.2017.08.045</idno>
					<note type="submission">Received date: 5 June 2017 Revised date: 9 August 2017 Accepted date: 11 August 2017 Preprint submitted to Journal of Information Sciences Templates</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.3" ident="GROBID" when="2023-07-28T14:29+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Drug-target interaction</term>
					<term>Molecular fingerprint</term>
					<term>Multivariate mutual information</term>
					<term>Feature selection</term>
					<term>Support vector</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Identifying Drug-Target Interactions (DTIs) is an important process in drug discovery. Traditional experimental methods are expensive and timeconsuming for detecting DTIs. Therefore, computational approaches provide many effective strategies to deal with this issue. In recent years, most of computational methods only use the information of drug-drug similarity or target-target similarity, which cannot perfectly capture all characteristics to identify DTIs. In this paper, we propose a novel computational model of DTIs prediction, based on machine learning methods. To improve the performance of prediction, we further use molecular substructure fingerprints, Multivariate Mutual Information (MMI) of proteins and network topology to represent drugs, targets and relationship between them. Moreover, we employ Support Vector Machine (SVM) and Feature Selection (FS) to construct model for predicting DTIs. Experiments of evaluation show that proposed approach achieves better results than other outstanding methods for feature-based DTIs prediction. The proposed approach achieves AUPRs of 0.899, 0.929, 0.821 and 0.655 on Enzyme, Ion Channel (IC), GPCR and Nuclear Receptor datasets, respectively. Compared with existing best methods, AUPRs are increased by 0.016 on Ion Channel datasets. In addition, our method obtains the second best performance on</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>Many biological signaling pathways involve autocrine ligand-receptor interactions, and cells contain lots of highly specific targets. Drugs act on the cell membrane by physical and chemical interactions. The analysis of DTIs is a key role of the drug discovery process, and many researchers spend a lot of 5 attentions in drug development on filtering receptor binding compounds. The computational technique is able to promote ligand research in an innovative drug-design environment.</p><p>In drug discovery, researchers require some labels to mark the binding of a drug to its receptor, which costs extra time and high error rate. Furthermore, 10 a quantitative ranking of drug-target interactions can be valuable in the drug discovery. Thus, it is very important to develop an efficient computational approach to detect DTIs. The interaction network is retrieved from the BRENDA <ref type="bibr" target="#b21">[23]</ref>, KEGG BRITE <ref type="bibr" target="#b14">[16]</ref>, SuperTarget <ref type="bibr" target="#b13">[15]</ref> and DrugBank <ref type="bibr" target="#b15">[17]</ref> databases. Most of the computational method is based on diversified information, including chemical 15 structure of drugs, sequence of proteins, network of instances.</p><p>In general, these computational methods can be classified as the following: docking simulation methods and machine learning methods. Docking simulation methods detect DTIs through the structural information of targets. But it is more time-consuming, compared with machine learning techniques. Determining 3D 20 structures of target is still quite difficult to obtain. So, lots of methods based on machine learning were developed to predict DTIs. The machine learning has been widely used in bioinformatics, and achieved very good results <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b30">31]</ref>. The</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M A N U S C R I P T</head><p>DTIs prediction can be regarded as a binary classification problem. What's more, machine learning methods can be subdivided into two subtypes: kernel matrices 25 method via similarity measures (i.e., genomic, chemical and pharmacological spaces) and feature vector-based method (DTI pairs are represented as feature vectors).</p><p>The main strategy of kernel matrices-based methods is to build kernel matrices through similarity between drugs and similarity between targets. Each DTIs Bayesian Matrix Factorization with Twin Kernels (KBMF2K) by GÃ¶nen, M. <ref type="bibr" target="#b10">[12]</ref>,</p><p>Regularized Least Squares model (RLS) by Laarhoven et al. <ref type="bibr" target="#b26">[27]</ref>, Bipartite Local Model (BLM) by Bleakley et al. <ref type="bibr" target="#b2">[3]</ref>, Bipartite Local Mode with Neighbor-based 40 Interaction-profile Inferring (BLM-NII) by Mei et al. <ref type="bibr" target="#b17">[19]</ref>, Laplacian Regularized Least Square based on interaction network (NetLapRLS) by Xia et al. <ref type="bibr" target="#b31">[32]</ref>,</p><p>Weighted Nearest Neighbor with Gaussian Interaction Profile kernels (WNN-GIP) by Laarhoven et al. <ref type="bibr" target="#b25">[26]</ref>, Collaborative Matrix Factorization (CMF) by Zheng et al. <ref type="bibr">[35]</ref> and Neighborhood Regularized Logistic Matrix Factorization (NRLMF) 45 by Liu et al. <ref type="bibr" target="#b16">[18]</ref>. NormMulInf is a semi-supervised learning framework, through collaborative filtering theory by Peng et al. <ref type="bibr" target="#b20">[22]</ref>. But the defect of the most kernel-based methods is that there are lots of samples to be classified with remarkable computational complexity. In addition, they did not consider the biological information in the protein domain. These methods did not fully 50 describe the protein sequence through some physical and chemical properties of amino acids. These properties can improve part of the prediction accuracy.</p><p>To avoid the problem, other machine learning approaches of feature vectorbased method extracted both drug and target features from molecular fingerprint</p><formula xml:id="formula_0">A C C E P T E D M A N U S C R I P T</formula><p>of drug and sequence descriptors of target as well as known drug-target inter-55 actions <ref type="bibr" target="#b5">[7,</ref><ref type="bibr" target="#b4">6,</ref><ref type="bibr" target="#b18">20]</ref>. Cao et al. <ref type="bibr" target="#b5">[7,</ref><ref type="bibr" target="#b4">6]</ref>  properties of protein sequences. In recent years, the similar approaches of sequence descriptors have been widely used to the protein-protein interaction prediction <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b8">10]</ref>. These substructures of drug and amino acid properties are 75 the key to detect DTI pairs. The DTIs are due to some substructures of drug binding with residues of target through the physical and chemical properties.</p><p>Therefore, MACCS and MMI can improve the prediction accuracy. From the perspective of polypharmacology, the network feature could be considered as a pharmacology properties <ref type="bibr" target="#b4">[6]</ref>. Limits of mainstream works (kernel matrices-based methods) mainly come 95 from the following aspects: (1) they did not consider the amino acid composition of target protein, when the similarity kernel matrix of target was constructed;</p><p>(2) the substructures of drug are redundant, and some of substructure are not presence; (3) lots of methods did not utilize the properties of network topology to build model. For above three problems, our approach has handled them by 100 some strategies. One of critical tasks of detecting DTIs by machine learning methods is feature extraction of DTIs. In this study, the protein representation method of mutual information is firstly utilized in the field of DTIs prediction.</p><p>In a protein sequence, mutual information of two amino acids describes the mutual dependence between these two amino acids. It deeply reflects amino acid 105 combinations in sequence. In addition, the dimension of original MACCS feature is redundant. Different from previous methods, we employ FS technology to reduce the redundant noise of feature space. The known relationships of DTIs are also extracted to improve prediction performance. The results of experiment confirms that the prediction performance of our model is comparable or even 110 better than state-of-the-art methods.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and Methods</head><p>In order to detect DTIs by computational approaches, we need to use a suitable way to represent the critical information of DTIs. The interaction between</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M</head><p>A N U S C R I P T drug and target protein greatly depends on the information not only from the 115 molecular substructure of drug compound but also from target protein sequence.</p><p>So, we represent drugs by utilizing their molecular substructure fingerprints and use k-gram representation to calculate MMI from protein sequences. Because the DTIs network profiling is essentially a cross-pharmacology-related profiling, the topology information of total training network could improve the performance 120 of prediction. Here, we use above DTIs information, FS technique and SVM to build prediction model for identifying DTIs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Representing Drug with Molecular Substructure Fingerprint</head><p>Here, we utilize molecular substructure fingerprints to describe drug. Molecular substructure fingerprint directly encodes the structure as a binary vector, 125 which can represent the presence or absence of some specific substructures in one drug. Moreover, it does not need 3D structure of the drug molecule. The fingerprint of MACCS has a MDL dictionary. The definition of MACCS fingerprint is available from OpenBabel (http://openbabel.org/). For MACCS fingerprint, chemical information (chem) of the drug is represented as a feature 130 vector f chem-M ACCS , via 166 common substructures. A demo of fingerprint with substructure dictionary is shown in Figure <ref type="figure" target="#fig_4">1</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Representing Target Protein with Multivariate Mutual Information from</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Amino Acid Sequence</head><p>Inspired by previous works <ref type="bibr" target="#b23">[24]</ref>, we utilize a novel approach to represent 135 critical information of targets. The k is the number of conjoint amino acids, and Shen et al. <ref type="bibr" target="#b23">[24]</ref> used the 3-gram feature representation. To obtain the neighboring local information of residues and their proximate amino acids, they developed a conjoint triad method. On the basis of k-gram feature description, we use MMI <ref type="bibr" target="#b7">[9]</ref> for fully representing amino acids in sequences.  amino acid types could be clustered into seven functional groups <ref type="bibr" target="#b23">[24]</ref>, which are detailedly shown in Table <ref type="table">1</ref>. As a result, all amino acids in sequences can be 145 divided into seven categories as C 0 , C 1 , ..., C 6 .</p><p>Table <ref type="table">1</ref>: Division of twenty amino acid types, based on dipoles and volumes of side chains.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>No.</head><p>Group Dipole scale Volume scale</p><formula xml:id="formula_1">C 0 A, G, V Dipole &lt; 1.0 Volume&lt; 50 C 1 C 1.0 &lt; Dipole &lt; 2.0 (form disulphide bonds) Volume&gt; 50 C 2 D, E Dipole &gt; 3.0 (opposite orientation) Volume&gt; 50 C 3 F, I, L, P Dipole &lt; 1.0 Volume&gt; 50 C 4 H, N, Q, W 2.0 &lt; dipole &lt; 3.0 Volume&gt; 50 C 5 K, R Dipole&gt; 3.0 Volume&gt; 50 C 6 M, S, T, Y 1.0 &lt; dipole &lt; 2.0 Volume&gt; 50 A C C E P T E D M A N U S C R I P T 2.2.</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Calculating Multivariate Mutual Information</head><p>Any 3 continuous amino acids are regarded as an unit. We only think about the basic ingredient of 3-length unit, and not consider about the order of three amino acids. The types of 3-gram is represented as</p><formula xml:id="formula_2">C 0 , C 0 , C 0 , C 0 , C 0 , C 1 , ..., 150 C 6 , C 6 , C 6 . What's more, the 2-gram are C 0 , C 0 , C 0 , C 1 , ..., C 6 , C 6 .</formula><p>The numbers of 2-gram and 3-gram are counted by the sliding window, which is shown in Figure <ref type="figure">2</ref>.</p><formula xml:id="formula_3">C 0 ={A,G,V} C 1 ={C} C 2 ={D,E} C 3 ={F,I,L,P} C 4 ={H,N,Q,W} C 5 ={K,R} C 6 ={M,S,T,Y} G Y AM T E C H W N Y R Transform encode C 0 C 6 C 0 C 6 C 6 C 2 C 1 C 4 C 4 C 4 C 6 C 5</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Original sequence</head><p>Re-encoding sequence In our work, the entropy and mutual information (MI) refer to mutual dependence between two amino acids on sequence. We calculate the 3-tuples MI 155 for 3-gram as:</p><formula xml:id="formula_4">(C 0 ,C 0 ,C 6 :1) 3-gram: (C 0 ,C 6 ,C 6 :2) (C 2 ,C 6 ,C 6 :1) ... (C 0 ,C 6 :3) 2-gram: (C 1 ,C 2 :1) (C 1 ,C 4 :1) ...</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The number of occurrences</head><formula xml:id="formula_5">I(a, b, c) = I(a, b) -I(a, b|c)<label>(1)</label></formula><p>where a, b and c are categories of three conjoint amino acids in one unit.</p><p>Then, the MI of I(a, b) and conditional MI of I(a, b|c) can be calculate as:</p><formula xml:id="formula_6">I(a, b) = f (a, b)log( f (a, b) f (a)f (b) ) (2a) I(a, b|c) = H(a|c) -H(a|b, c)<label>(2b)</label></formula><p>where f (a, b) is the frequency of a and b arising in 2-gram on one amino acid sequence, and f (a) is the frequency of a arising on one amino acid sequence.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M A N U S C R I P T</head><p>The H(a|c) and H(a|b, c) are calculated as:</p><formula xml:id="formula_7">H(a|c) = -f (a|c)log(f (a|c)) (3a) = - f (a, c) f (c) log( f (a, c) f (c) ) (3b) H(a|b, c) = -f (a|b, c)log(f (a|b, c)) (3c) = - f (a, b, c) f (b, c) log( f (a, b, c) f (b, c) ) (3d)</formula><p>where f (a, b, c) denotes the frequency of a, b and c appearing in 3-tuples on one amino acid sequence.</p><p>To avoid values of 3-tuples and 2-tuples MI being infinity, we define the 160 frequency as:</p><formula xml:id="formula_8">f (a) = n a + 1 L + 1 (<label>4</label></formula><formula xml:id="formula_9">)</formula><p>where L denotes the length of sequence, n a denotes the occurrence number of category a appearing on this amino acid sequence. f (a, b) and f (a, b, c) are also calculated by the similar method.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">DTIs Network Topology</head><p>The DTI network could be considered as a bipartite graph, which contains edges describing real DTIs. Cao et al. <ref type="bibr" target="#b4">[6]</ref> and Xia et al. <ref type="bibr" target="#b31">[32]</ref> incorporated the network information to analyze DTIs. DTI network topology can be considered as a features of pharmacology.</p><p>175</p><p>We can obtain the interaction information of one drug </p><formula xml:id="formula_10">D i (i = 1, 2, 3, ..., n d ,</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Feature Selection and Support Vector Machine Model Construction</head><p>The feature space of drug-target complex is made up of bio (MMI), chem  Then, it will rank the features based on their significances. Finally, we select top-ranked features as the input vector to training the new SVM model.</p><p>The architecture of our proposed method is shown in Figure <ref type="figure" target="#fig_6">3</ref>.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M</head><p>A N U S C R I P T</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>200</head><p>We test our method on balanced DTIs datasets described by Cao et al. <ref type="bibr" target="#b4">[6]</ref> to evaluate the performance of our model. First, we analyze the performance of features, containing bio-MMI, chem-MACCS and net. The SVM-RFE+CBR <ref type="bibr" target="#b32">[33]</ref> technique is also employed in the balanced DTIs datasets. Second, we compare our approach with other outstanding methods containing BLM by Bleakley NetLapRLS by Xia et al. <ref type="bibr" target="#b31">[32]</ref>, multiple features fusion by Cao et al. <ref type="bibr" target="#b4">[6]</ref> on the balanced bechmark datasets <ref type="bibr" target="#b4">[6]</ref>. The proposed method achieves the better values of AUCs, which are 0.985, 0.988, 0.952 and 0.945 on four balanced datasets, respectively.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>210</head><p>The imbalanced DTIs datasets are also used to evaluate our method. And we compare the proposed method with other methods containing NetLapRLS <ref type="bibr" target="#b31">[32]</ref>, WNN-GIP <ref type="bibr" target="#b25">[26]</ref>, BLM-NII <ref type="bibr" target="#b17">[19]</ref>, KBMF2K <ref type="bibr" target="#b10">[12]</ref>, CMF <ref type="bibr">[35]</ref>, NormMulInf <ref type="bibr" target="#b20">[22]</ref> and NRLMF <ref type="bibr" target="#b16">[18]</ref>. Our method achieves average AUCs of 0.983, 0.991, 0.961 and 0.916 on four imbalanced datasets, respectively.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>215</head><p>Park and Marcotte <ref type="bibr" target="#b19">[21]</ref> indicated that the flaw of pair-input prediction existed in many previous computational methods. Thus, we test our approach based on Park's evaluation method.</p><p>At last, we test the performance of potential DTIs of our method on benchmark. We set the balanced DTIs as training sets. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Gold Standard Dataset</head><p>A gold standard dataset is used as a benchmark to evaluate our work, which was released by Yamanishi et al. <ref type="bibr">[34]</ref>. All drug-target interacting or noninteracting pairs were taken from BRENDA <ref type="bibr" target="#b21">[23]</ref>, DrugBank <ref type="bibr" target="#b15">[17]</ref>, SuperTarget <ref type="bibr" target="#b13">[15]</ref> and KEGG BRITE <ref type="bibr" target="#b14">[16]</ref> databases.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>225</head><p>Targets in these databases can be categorized into four species, including enzymes, IC, GPCR and nuclear receptors, as shown in To resolve unbalanced problem of DTIs, some researchers <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b5">7,</ref><ref type="bibr" target="#b4">6,</ref><ref type="bibr" target="#b18">20]</ref> randomly selected negative samples from unknow interacting pairs, in order to make the size of negative samples reaching to the size of positive samples. So,</p><formula xml:id="formula_11">235</formula><p>we evaluate our method on the mentioned dataset, which is collected by Cao et al. <ref type="bibr" target="#b4">[6]</ref>. The details of balanced dataset are described in Cao's work <ref type="bibr" target="#b4">[6]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.2.">Imbalanced Dataset</head><p>The gold standard dataset only has positive samples, so remaining noninteraction drug-target pairs are regarded as negative. As a result, the number 240 of non-interaction pairs (majority class) is much more than that of interaction pairs (minority class), and the ratio is larger than 99 (292554 : 2926) on Enzyme, 28 (41364 : 1476) on Ion channel, 32 (20550 : 635) on GPCR, and 14 (1314 : 90) on Nuclear classes.   In addition, we also test the feedforward neural networks on the balanced 290 datasets. Alhamdoosh and Wang <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b28">29]</ref> employed the Random Vector Functional Link (RVFL) networks as base components, and incorporated with the Negative Correlation Learning (NCL) strategy for building neural network ensembles.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">Evaluation Measurements</head><p>Their proposed algorithm was named as fast Decorrelated Neural Network Ensembles (DNNE) <ref type="bibr" target="#b0">[1]</ref>. The results are also shown in Table <ref type="table" target="#tab_5">3</ref>. The DNNE is 295 better than SVM (non feature selection) on Enzymes (0.9821 over 0.9815), and Ion Channel (0.9841 over 0.9817), respectively. And the performance of DNNE is close to RF model. The main reason of the result is that the neural network could Feature Mapping (FM) <ref type="bibr" target="#b28">[29]</ref> and DNNE is also an ensemble learning approach.</p><p>The hidden feature vectors of each base RVFL network in the ensemble model 300 cover different regions in the feature space.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.2.">Selecting Top Rank Features</head><p>Many features are either redundant or irrelevant, and some of them can be removed without incurring much loss of information. The dimension of original bio-MMI feature and chem-MACCS is 119 and 166, respectively. However, not 305 all of drug molecular substructures are present in these drugs of four datasets.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M</head><p>A N U S C R I P T    In the Table <ref type="table" target="#tab_6">4</ref>, we can see that each type of feature can be selected as part of it. The dimension of original chem-MACCS is 166. Some dimensions of the chem-MACCS feature are all 0 value. And, we remove the these dimensions of the Among them, the network features occupy more than one-third. What's more, the bio-MMI and chem-MACCS features are also essential. On Enzyme and GPCR, the percentages of selected bio-MMI feature are 84.9% (101/119) 340 and 73.1% (87/119), respectively. On the GPCR, the percentage of selected chem-MACCS feature is 80.0% (120/150). However, more features are also removed by SVM-RFE+CBR. On the Nuclear Receptor, 78.9% ((119-25)/119) of bio-MMI feature and 93.5% ((139-9)/139) of chem-MACCS feature are removed, respectively. 345</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.3.">Comparing with Existing Approaches</head><p>We compare our model with other existing predictors throught five-fold cross validation on balanced dataset for four species, as showed in Table <ref type="table" target="#tab_8">5</ref>. These methods include BGL[34], BLM <ref type="bibr" target="#b2">[3]</ref>, NetLapRLS <ref type="bibr" target="#b31">[32]</ref>, RLS <ref type="bibr" target="#b26">[27]</ref>, Bigram-PSSM <ref type="bibr" target="#b18">[20]</ref>,</p><p>ChemTher <ref type="bibr" target="#b29">[30]</ref> and Cao's work <ref type="bibr" target="#b4">[6]</ref>. Obviously, high prediction AUCs of 0.985,    a bio represents the bio-MMI feature.</p><p>b net represents the net feature.</p><p>c chem represents the chem-MACCS feature.</p><p>performance of prediction on other datasets. Although the BLM achieves best AUC(0.955) on the GPCR dataset, the average AUCs of our method (bio-MMI + chem-MACCS + net features) with feature selection is increased 0.009, 0.015, 355 and 0.064 compared with BLM <ref type="bibr" target="#b2">[3]</ref> on the datasets of Enzyme, IC and Nuclear receptor, respectively. The advantage of our method is obvious on the Nuclear receptor dataset.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5.">Performance on Imbalanced Dataset</head><p>We also test on imbalanced benchmark dataset throught five-fold cross valida-360 tion, as showed in Table <ref type="table" target="#tab_9">6</ref>. The optimized parameter sittings of balanced datasets are also employed on imbalanced datasets (including Enzymes, IC, GPCR and Nuclear). The State-of-the-Arts methods include NetLapRLS <ref type="bibr" target="#b31">[32]</ref>, WNN-GIP <ref type="bibr" target="#b25">[26]</ref>,</p><p>BLM-NII <ref type="bibr" target="#b17">[19]</ref>, KBMF2K <ref type="bibr" target="#b10">[12]</ref>, NRLMF <ref type="bibr" target="#b16">[18]</ref>, CMF <ref type="bibr">[35]</ref> and NormMulInf <ref type="bibr" target="#b20">[22]</ref>  * Results excerpted from <ref type="bibr" target="#b4">[6]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M</head><p>A N U S C R I P T The best results in each column are in bold faces and the second best results are underlined.</p><p>a Features have been selected by SVM-RFE+CBR.</p><p>b Results excerpted from <ref type="bibr" target="#b16">[18]</ref>.</p><p>c Results excerpted from <ref type="bibr" target="#b20">[22]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M</head><p>A N U S C R I P T   In this part, we test the ability of our method on identifying new DTIs. We use four biological databases (ChEMBL(C) <ref type="bibr" target="#b9">[11]</ref>, KEGG(K) <ref type="bibr" target="#b14">[16]</ref>, DrugBank(D) <ref type="bibr" target="#b15">[17]</ref> and Matador(M) <ref type="bibr" target="#b11">[13]</ref>) to confirm whether new detected DTIs are presence.</p><p>The new DTIs predicted by our method can be ranked by interaction probabilities, as shown in Table <ref type="table" target="#tab_12">8</ref>. Our method detects potential DTIs, which are present </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.8.">Running Time</head><p>The time complexity of NRLMF is O(iter â¢ r â¢ m â¢ n), where iter, m, n and r denoted the number of iterations, targets, drugs and dimensionality of mapping space (targets and drugs are mapped into a space of r dimensionality) <ref type="bibr" target="#b16">[18]</ref>. The   </p><formula xml:id="formula_12">(N 3 s + (N 2 s + N s â¢ d) â¢ m â¢ n).</formula><p>Therefore, efficiency of our model is close to NRLMF (better than KBMF2K and CMF) <ref type="bibr" target="#b16">[18]</ref>.</p><p>To further evaluate the performance of our method, we test the running time on four datasets. Related source codes are collected from other researchers' works 425 <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b10">12,</ref><ref type="bibr" target="#b16">18]</ref> (including BLM-NII, NetLapRLS, WNN-GIP, NRLMF, CMF and KBMF2K). These codes are written by python or MATLAB script. We test our method and these methods on same platform by 10 times. The experiements are carried out on a computer with Intel Core i3 4160 (3.6 GHz 2-core four threads CPU), 16 GB memory and Windows OS. Detailed results of running time are 430 shown in Table <ref type="table" target="#tab_13">9</ref>. The running time of our method is closed to NRLMF, and shorter than CMF and KBMF2K. WNN-GIP, NetLapRLS and BLM-NII achieve the better performance of running time, but obtain the worse performance of accuracy.  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>30 dataset</head><label>30</label><figDesc>can be described by three types of information in the form of three matrices: (1) the drug-drug similarity matrix; (2) the target-target similarity matrix and (3) the DTIs matrix. The drug similarities are based on the chemical structure. The target similarities are calculated based on target sequences. They used known interaction to detect new interaction with drug-drug and 35 target-target similarity matrix in DTIs network. This kind of method contains Bipartite Graph Learning (BGL) model by Yamanishi et al. [34], Kernelized</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc>used three global descriptors (Composition, Transition and Distribution) to reflect biological properties of target sequence and encoded drug molecules with MACCS substructure fingerprint representing. Composition, Transition and Distribution (CTD) contain much information of one protein sequence. These features were fed into Random Forest (RF) model 60 for training and prediction. Zaynab et al. [20] used the bi-gram features and molecular substructure fingerprint to represent target and drug, respectively. But most of feature vector-based methods did not consider the network feature. In essence, network feature contains the association between drug-target pairs. Inspired by above methods, we propose a computational approach to identify 65 DTIs by combining three types of information: (1) properties of chemistry (chem), the substructure fingerprint; (2) properties of biology (bio), containing physicochemical properties; (3) properties of network topology (net), containing drug-target relationship of training network. In this article, we utilize MACCS fingerprint to represent drug molecule, and use MMI on sequence to represent 70 target protein [10]. The MACCS fingerprint can describe the substructures of drug molecules, and the MMI can further extract the physical and chemical</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>80</head><label></label><figDesc>Moreover, we employ Support Vector Machine (SVM) and Feature Selection (FS) to develop prediction system for benchmark dataset. The FS can avoid the height dimension of feature and enhanced generalization by reducing the overfitting. Comparing with other machine learning algorithm, the optimization goal of SVM is to minimize the risk of structured, rather than the least risk ofA C C E P T E D M A N U S C R I P Texperience. By the maximum-margin hyperplanes, SVM reduces the dependency on data size and data distribution. In practice, we find that the proposed approach achieves high prediction accuracy by combining MACCS, MMI, network feature, FS and SVM. Our method are evaluated on four datasets. The results show that the proposed approach achieves better Area Under the Precision-90 Recall curves (AUPRs) on Enzyme, Ion Channel and Guanosine-binding Protein Coupled Receptor (GPCR) datasets. In addition, we also test the performance of potential DTIs of our model on above four benchmarks. The advantages of our approach are due to feature extraction methods and feature selection methods.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>140 2 . 2 . 1 .</head><label>221</label><figDesc>Classifying Amino AcidsVolumes and dipoles of 20 amino acids, which reflect hydrophobic and electrostatic, can dominate the protein-protein interaction. The 20 standardA C C E P T E D M A N U S C R I P T</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 1 :</head><label>1</label><figDesc>Figure 1: An example of fingerprint with the substructure fingerprint dictionary.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 2 : 3 -</head><label>23</label><figDesc>Figure 2: 3-gram or 2-gram feature representation.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>3 -</head><label>3</label><figDesc>tuples (84 dimensions) and 2-tuples (28 dimensions) MI of I(a, b, c) and 165 I(a, b) are extracted from one amino acid sequence, respectively. What's more, we calculate the frequency of each categories appearing on this amino acid sequence. Finally, we build a 119-dimensional vector v bio-M M I for representing each protein target information (bio). We normalize v bio-M M I via the min-max normalization, and produce a new vector f bio-M M I .</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc>170</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>n</head><label></label><figDesc>d is the number of drugs in DTI network) and one target P j (j = 1, 2, 3, ..., n p , n p is the number of proteins in DTI network), based on the interaction information of drug D i and other targets excluding P j . We can represent the interaction A C C E P T E D M A N U S C R I P T information of drug D i as one (n p -1)-dimensional binary profile, corresponding 180 to the presence (1) or absence (0) of association between this drug and each target. Thus, we can get a [(n p -1) + (n d -1)]-dimensional f net to represent the DTI network.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>[ 8 ]</head><label>8</label><figDesc>. We define a [119 + (n d -1) + (n p -1) + 166]-dimentional feature vector F = 195 (f bio-M M I , f net , f chem-M ACCS ) as the input data of the FS (SVM-RFE+CBR).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>Figure 3 :</head><label>3</label><figDesc>Figure 3: Schematic diagram of drug-target interaction prediction.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head></head><label></label><figDesc>205 et al.[3], BGL model by Yamanishi et al.[34], RLS by Laarhoven et al.[27],</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_13"><head></head><label></label><figDesc>220</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_14"><head>245</head><label></label><figDesc>To test the robustness of our approach, we repeat random selection of training set and test set, model-building and model-evaluating. This process is 5-fold cross validation. The Area Under the Receiver Operating Characteristic (AUC)A C C E P T E D M A N U S C R I P Tand Average area under the precision-recall curve (AUPR) are both used as the evaluation metrics.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_15"><head>250 3 . 4 .</head><label>34</label><figDesc>Performance on Balanced DatasetWe use ten balanced DTIs datasets to analysis the prediction performance of bio, chem and net features. In the experiment, the FS technique could improve the performance of prediction and reduce overfitting. The proposed method is also compared with other good methods on the balanced datasets. 2553.4.1. Analysis of bio, chem and net FeaturesTo analyze bio-MMI, chem-MACCS and net features, we test on ten balanced datasets for each class. Cao et al.<ref type="bibr" target="#b4">[6]</ref> used gold standard dataset and ten negative datasets randomly generated from non-interacting pairs. We use the grid search approach to get the optimized SVM parameter, and perform 5-fold 260 cross-validation on ten balanced datasets for each class. The average AUCs of our method (bio-MMI + chem-MACCS features under feature selection) is increased 0.01, 0.0061, 0.0078 and 0.0689 compared with no feature selection on the datasets of Enzymes, IC, GPCR and Nuclear receptor, respectively. SVM-RFE+CBR could improve the accuracy of prediction by 265 eliminating the noise of features. The AUCs of bio-MMI + chem-MACCS + net features under feature selection is higher than no net feature method (bio-MMI + chem-MACCS features under feature selection) on Enzymes (0.9854 over 0.9356), Ion Channel (0.9878 over 0.9355), GPCR (0.9524 over 0.8996) and Nuclear receptor (0.9452 over 0.8850), respectively. The model by bio-MMI 270 + chem-MACCS + net features indeed improves the prediction performance by adding network information. Results of prediction for these features are shown in Table3. We combine the feature of bio-MMI and chem-MACCS, named Combine1 in these tables. The bio-MMI + chem-MACCS + net feature, bio-CTD + chem-MACCS feature and bio-CTD + chem-MACCS + net feature,</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_16"><head>Figure 5 :</head><label>5</label><figDesc>Figure 5: AUPR obtained under feature selection on balanced benchmark dataset for four classes. The red curve is the fusion feature of bio-MMI and chem-MACCS. The blue curve is the fusion feature of bio-MMI, chem-MACCS and net.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_17"><head>c 6 Figure 7 ,</head><label>67</label><figDesc>FM represents the feature mapping of DNNE. Some dimensions of the MACCS are all 0 value. In this case, SVM can't obtain the best predictive performance. Hence we remove these dimensions of the chem-MACCS feature (by removing those dimensions of zero variance). What's more, different datasets have various network sizes, and dimensions of net feature 310 are also different. On four datasets, feature importance scores are presented in Figure Figure 8 and Figure 9, respectively. These scores are estimated by SVM-RFE+CBR. The higher score means more important. The blue, green and red bars represent the bio-MMI, net and chem-MACCS feature, respectively. 315 Obviously, the bio-MMI and net features play major roles on Enzyme, IC and Nuclear receptor datasets. On the GPCR, three types of features play almost the same effect. Through these scores, we sort them from high to low. To obtain the optimized number of top rank features, we test different numbers of dimensions (from 10 dimensions to original dimensions). As shown in Figure 10, we get 320 top 485, 245, 345 or 70 dimensions with ACC on balanced benchmark dataset for Enzymes, IC, GPCR and Nuclear classes, respectively. We utilize the grid A C C E P T E D M A N U S C R I P T search approach to get the optimized SVM parameter for Enzymes (C = 16 and Î³ = 0.0313), Ion Channel (C = 8 and Î³ = 0.0313), GPCR (C = 256 and Î³ = 0.002) and Nuclear (C = 2 and Î³ = 0.125) with RBF kernel. And the 325 parameter of CBR is 0.9 (correlation coefficient threshold for highly correlation features).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_18"><head></head><label></label><figDesc>330 chem-MACCS feature. So, the dimensions of chem-MACCS feature are different on the four datasets. What's more, different datasets have different network sizes, the dimensions of net feature are different. The DOF represents the dimension of original fusion feature (bio-MMI + chem-MACCS + net). The DSF represents the dimension of selected fusion feature (bio-MMI + chem-MACCS + net have 335 been selected by SVM-RFE+CBR). The DO represents the dimension of original sub-feature. And the DS represents the dimension of selected sub-feature.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_19"><head>350 0 .Figure 6 :</head><label>06</label><figDesc>Figure 6: The feature scores on the Enzyme dataset. The x-axis represents the feature index.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_20"><head>Figure 7 :Figure 8 :</head><label>78</label><figDesc>Figure 7: The feature scores on the GPCR dataset. The x-axis represents the feature index.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_21"><head>Figure 9 :Figure 10 :</head><label>910</label><figDesc>Figure 9: The feature scores on the Nuclear receptor dataset. The x-axis represents the feature index.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_22"><head>Figure 11 :</head><label>11</label><figDesc>Figure 11: AUC obtained on imbalanced benchmark dataset for four species, via five-fold cross validation.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_23"><head>405</head><label></label><figDesc>figshare.com/s/53bf5a6065f3911d46f6).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_24"><head>415</head><label></label><figDesc>time complexity of KBMF2K and CMF are O(iter â¢ (râ¢ m 3 + r â¢ n 3 + r 3 )) and O(iter â¢ (r 2 â¢ (m + n) 2 + r 3 â¢ (m + n)))<ref type="bibr" target="#b16">[18]</ref>. Let l be the number of training points,A C C E P T E D MA N U S C R I P T</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_25"><head></head><label></label><figDesc>S C R I P T N s be the number of support vectors (SVs), and d be the dimension of the input data. The time complexity of training our SVM model is O(N 3 s + N 2 s â¢ l + N s â¢ d â¢ l) [4], and l â m â¢ n. In most cases, N s are not at the upper bound, and N s /l 1.420So, the time complexity of our model is O</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_26"><head>4 .</head><label>4</label><figDesc>Conclusion and Discussion435Most of the previous methods are based on similarity matrix. But, the similarity matrices of drug and target could not extract more key property from drug-target interaction. To resolve above issue, a few methods were proposed on information of protein sequences and drug topological substructure. To improve the performance of prediction, we further use the molecular substructure 440 fingerprints, MMI of protein sequences and network topology to represent the drug, target and relationship between them. The results of our experiment have demonstrated the ability of the proposed approach. Our method achieves AUPRs of 0.899, 0.929, 0.821 and 0.655 on Enzyme, IC, GPCR and Nuclear Receptor datasets, respectively. 445 The major challenges of DTIs prediction include: (1) fully describing the critical information of DTIs (extracting the feature of DTIs); (2) the problem of imbalanced data. For the first problem, we utilize molecular substructure fingerprint of drug, a novel MMI feature of target and topology of network to describe DTIs information. And the MMI feature performed well. The 450 second problem of imbalanced data is common in computational biology. The performance of AUPR can also be further improved on imbalanced data of DTIs.In generally, SVM is used to handle the imbalanced classification problem by class weight. However, the performance of weighted SVM is poor on extremely imbalanced data (the ratio between majority and minority examples is usually 455 larger) and in many complex tasks. To reduce model complexity and improve computational efficiency, we only consider the model of weighted SVM (without sampling or filtering) in this study. Other better machine learning approaches, such as Neural Networks with Random Weights<ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b28">29]</ref> and Sparse Representation model, can be used to build classifier rather than SVM. In Alhamdoosh and 460 Wang's work<ref type="bibr" target="#b0">[1]</ref>, DNNE algorithm built ensemble model with bootstrap sampling and weighting sub-classifiers. DNNE algorithm is an effective strategy to deal with the imbalanced problem. The Stochastic Configuration Networks Ensemble (SCNE)<ref type="bibr" target="#b28">[29]</ref> is a newly developed ensemble, which always outperforms the DNNE.A C C E P T E D M A N U S C R I P TIn the future, we will build the classification model by strategy of SCNE or 465 even utilize the SCNE on the imbalanced data of DTIs. The ensemble classifier (with bootstrap sampling and weighting sub-classifiers) could further improve the performance of DTIs prediction. A C C E P T E D M A N U S C R I P T [5] Cortes C. and Vapnik V. Support-vector networks. Machine Learning,</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc>There are 664, 204, 95 and 26 targets and 445, 210, 223 and 54 drugs in these four classes,</figDesc><table><row><cell>respectively. The number of known interactions are 2926, 1476, 635 and 90,</cell></row><row><cell>respectively.</cell></row><row><cell>M A N U S C R I P T</cell></row><row><cell>A C C E P T E D</cell></row></table><note><p>230</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 :</head><label>2</label><figDesc>A gold standard dataset with four different classes.</figDesc><table><row><cell>Database</cell><cell cols="3">Drug Target Interactions</cell></row><row><cell>Enzyme</cell><cell>445</cell><cell>664</cell><cell>2926</cell></row><row><cell>Ion channel</cell><cell>210</cell><cell>204</cell><cell>1476</cell></row><row><cell>GPCR</cell><cell>223</cell><cell>95</cell><cell>635</cell></row><row><cell>Nuclear receptor</cell><cell>54</cell><cell>26</cell><cell>90</cell></row><row><cell>3.2. Dataset</cell><cell></cell><cell></cell><cell></cell></row><row><cell>3.2.1. Balanced Dataset</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 3 :</head><label>3</label><figDesc>Comparison of the AUC between different features on four balanced datasets.</figDesc><table><row><cell>Feature</cell><cell>FS a</cell><cell>Model</cell><cell>Enzymes</cell><cell>Ion Channel</cell><cell>GPCR</cell><cell>Nuclear receptor</cell></row><row><cell>Combine1</cell><cell>none</cell><cell>SVM</cell><cell>0.9256Â±0.0027</cell><cell>0.9294Â±0.0049</cell><cell>0.8918Â±0.0078</cell><cell>0.8161Â±0.0342</cell></row><row><cell>Combine1</cell><cell>RFE b</cell><cell>SVM</cell><cell>0.9356Â±0.0055</cell><cell>0.9355Â±0.0047</cell><cell>0.8996Â±0.0057</cell><cell>0.8850Â±0.0475</cell></row><row><cell>Combine2</cell><cell>none</cell><cell>SVM</cell><cell>0.9815Â±0.0041</cell><cell>0.9817Â±0.0052</cell><cell>0.9341Â±0.0045</cell><cell>0.8665Â±0.0231</cell></row><row><cell>Combine2</cell><cell>RFE b</cell><cell>SVM</cell><cell cols="4">0.9854Â±0.0017 0.9878Â±0.0013 0.9524Â±0.0041 0.9452Â±0.0212</cell></row><row><cell>Combine3[6]</cell><cell>RF</cell><cell>RF</cell><cell>0.9438Â±0.0022</cell><cell>0.9289Â±0.0031</cell><cell>0.8906Â±0.0066</cell><cell>0.7996Â±0.0278</cell></row><row><cell>Combine4[6]</cell><cell>RF</cell><cell>RF</cell><cell>0.9789Â±0.0007</cell><cell>0.9865Â±0.0010</cell><cell>0.9508Â±0.0032</cell><cell>0.9238Â±0.0162</cell></row><row><cell>Combine2</cell><cell cols="3">FM c DNNE[1] 0.9821Â±0.0033</cell><cell>0.9841Â±0.0039</cell><cell>0.9321Â±0.0041</cell><cell>0.8608Â±0.0205</cell></row><row><cell>Combine4</cell><cell cols="3">FM c DNNE[1] 0.9756Â±0.0032</cell><cell>0.9837Â±0.0037</cell><cell>0.9401Â±0.0055</cell><cell>0.8598Â±0.0186</cell></row></table><note><p><p>a FS represents the method of feature selection.</p>b RFE represents the method of SVM-RFE+CBR.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 4 :</head><label>4</label><figDesc>The numbers of optimized top-rank features for four species.</figDesc><table><row><cell>Dataset</cell><cell cols="2">DOF DSF</cell><cell>bio a</cell><cell cols="2">net b</cell><cell>chem c</cell></row><row><cell></cell><cell></cell><cell></cell><cell>DO DS</cell><cell>DO</cell><cell>DS DO DS</cell></row><row><cell>Enzyme</cell><cell cols="5">1382 485 119 101 1107 295 156 89</cell></row><row><cell>GPCR</cell><cell cols="3">585 345 119 87</cell><cell cols="2">316 138 150 120</cell></row><row><cell>Ion Channel</cell><cell cols="3">679 245 119 70</cell><cell cols="2">412 141 148 34</cell></row><row><cell cols="2">Nuclear Receptor 336</cell><cell cols="2">70 119 25</cell><cell>78</cell><cell>36 139</cell><cell>9</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>Table 5 :</head><label>5</label><figDesc>Overall AUC values of different methods on balanced dataset for four species.</figDesc><table><row><cell>Method</cell><cell cols="4">Enzyme Ion Channel GPCR Nuclear receptor</cell></row><row><cell>bio-MMI + chem-MACCS</cell><cell>0.926</cell><cell>0.925</cell><cell>0.886</cell><cell>0.816</cell></row><row><cell>bio-MMI + chem-MACCS + net</cell><cell>0.982</cell><cell>0.982</cell><cell>0.934</cell><cell>0.867</cell></row><row><cell>bio-MMI + chem-MACCS a</cell><cell>0.936</cell><cell>0.936</cell><cell>0.900</cell><cell>0.885</cell></row><row><cell cols="2">bio-MMI + chem-MACCS + net a 0.985</cell><cell>0.988</cell><cell>0.952</cell><cell>0.945</cell></row><row><cell>bio-CTD + chem-MACCS *</cell><cell>0.944</cell><cell>0.929</cell><cell>0.891</cell><cell>0.800</cell></row><row><cell cols="2">bio-CTD + chem-MACCS + net * 0.979</cell><cell>0.987</cell><cell>0.951</cell><cell>0.924</cell></row><row><cell>BGL *</cell><cell>0.904</cell><cell>0.851</cell><cell>0.899</cell><cell>0.843</cell></row><row><cell>BLM *</cell><cell>0.976</cell><cell>0.973</cell><cell>0.955</cell><cell>0.881</cell></row><row><cell>NetLapRLS *</cell><cell>0.956</cell><cell>0.947</cell><cell>0.931</cell><cell>0.856</cell></row><row><cell>RLS *</cell><cell>0.978</cell><cell>0.984</cell><cell>0.954</cell><cell>0.922</cell></row><row><cell>Bigram-PSSM[20]</cell><cell>0.948</cell><cell>0.889</cell><cell>0.872</cell><cell>0.869</cell></row><row><cell>ChemTher[30]</cell><cell>0.975</cell><cell>0.971</cell><cell>0.946</cell><cell>0.907</cell></row></table><note><p>a Features have been selected by SVM-RFE+CBR.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head>Table 6 :</head><label>6</label><figDesc>Overall AUC and AUPR values of different methods on imbalanced dataset for four species.</figDesc><table><row><cell>Evaluation</cell><cell>Method</cell><cell>Enzyme</cell><cell>Ion Channel</cell><cell>GPCR</cell><cell>Nuclear receptor</cell></row><row><cell></cell><cell>Our method a</cell><cell cols="3">0.983Â±0.003 0.991Â±0.002 0.961Â±0.007</cell><cell>0.916Â±0.040</cell></row><row><cell></cell><cell cols="2">Our method(no net) a 0.946Â±0.004</cell><cell>0.952Â±0.003</cell><cell>0.910Â±0.012</cell><cell>0.855Â±0.032</cell></row><row><cell></cell><cell>NetLapRLS b</cell><cell>0.972Â±0.002</cell><cell>0.969Â±0.003</cell><cell>0.915Â±0.006</cell><cell>0.850Â±0.021</cell></row><row><cell>AUC</cell><cell>BLM-NII b</cell><cell>0.978Â±0.002</cell><cell>0.981Â±0.002</cell><cell>0.950Â±0.006</cell><cell>0.905Â±0.023</cell></row><row><cell></cell><cell>WNN-GIP b</cell><cell>0.964Â±0.003</cell><cell>0.959Â±0.003</cell><cell>0.944Â±0.005</cell><cell>0.901Â±0.017</cell></row><row><cell></cell><cell>KBMF2K b</cell><cell>0.905Â±0.003</cell><cell>0.961Â±0.003</cell><cell>0.926Â±0.006</cell><cell>0.877Â±0.023</cell></row><row><cell></cell><cell>CMF b</cell><cell>0.969Â±0.002</cell><cell>0.981Â±0.002</cell><cell>0.940Â±0.007</cell><cell>0.864Â±0.026</cell></row><row><cell></cell><cell>NRLMF b</cell><cell cols="3">0.987Â±0.001 0.989Â±0.001 0.969Â±0.004</cell><cell>0.950Â±0.011</cell></row><row><cell></cell><cell>NormMulInf c</cell><cell>0.958Â±N/A</cell><cell>0.939Â±N/A</cell><cell>0.948Â±N/A</cell><cell>0.941Â±N/A</cell></row><row><cell></cell><cell>Our method a</cell><cell cols="3">0.899Â±0.007 0.929Â±0.020 0.821Â±0.022</cell><cell>0.655Â±0.076</cell></row><row><cell></cell><cell cols="2">Our method(no net) a 0.673Â±0.013</cell><cell>0.709Â±0.017</cell><cell>0.526Â±0.029</cell><cell>0.457Â±0.057</cell></row><row><cell></cell><cell>NetLapRLS b</cell><cell>0.789Â±0.005</cell><cell>0.837Â±0.009</cell><cell>0.616Â±0.015</cell><cell>0.465Â±0.044</cell></row><row><cell>AUPR</cell><cell>BLM-NII b</cell><cell>0.752Â±0.011</cell><cell>0.821Â±0.012</cell><cell>0.524Â±0.024</cell><cell>0.659Â±0.039</cell></row><row><cell></cell><cell>WNN-GIP b</cell><cell>0.706Â±0.017</cell><cell>0.717Â±0.020</cell><cell>0.520Â±0.021</cell><cell>0.589Â±0.034</cell></row><row><cell></cell><cell>KBMF2K b</cell><cell>0.654Â±0.008</cell><cell>0.771Â±0.009</cell><cell>0.578Â±0.018</cell><cell>0.534Â±0.050</cell></row><row><cell></cell><cell>CMF b</cell><cell>0.877Â±0.005</cell><cell>0.923Â±0.006</cell><cell>0.745Â±0.013</cell><cell>0.584Â±0.042</cell></row><row><cell></cell><cell>NRLMF b</cell><cell>0.892Â±0.006</cell><cell>0.906Â±0.008</cell><cell>0.749Â±0.015</cell><cell>0.728Â±0.041</cell></row><row><cell></cell><cell>NormMulInf c</cell><cell>0.932Â±N/A</cell><cell>0.913Â±N/A</cell><cell>0.879Â±N/A</cell><cell>0.857Â±N/A</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_11"><head>Table 7 :</head><label>7</label><figDesc>Overall AUC and AUPR values of dataset for four classes.</figDesc><table><row><cell></cell><cell>Evaluation</cell><cell>Class</cell><cell>Enzyme</cell><cell>Ion Channel</cell><cell>GPCR</cell><cell>Nuclear receptor</cell></row><row><cell></cell><cell></cell><cell>C1</cell><cell cols="3">0.983Â±0.003 0.991Â±0.002 0.961Â±0.007</cell><cell>0.916Â±0.040</cell></row><row><cell></cell><cell>AUC</cell><cell>C2 C3</cell><cell cols="3">0.949Â±0.012 0.955Â±0.014 0.907Â±0.039 0.886Â±0.015 0.853Â±0.022 0.862Â±0.033</cell><cell>0.849Â±0.057 0.828Â±0.043</cell></row><row><cell></cell><cell></cell><cell>C4</cell><cell cols="3">0.816Â±0.037 0.801Â±0.042 0.782Â±0.038</cell><cell>0.774Â±0.051</cell></row><row><cell></cell><cell></cell><cell>C1</cell><cell cols="3">0.899Â±0.007 0.929Â±0.020 0.821Â±0.022</cell><cell>0.655Â±0.076</cell></row><row><cell></cell><cell>AUPR</cell><cell>C2 C3</cell><cell cols="3">0.795Â±0.019 0.809Â±0.026 0.551Â±0.031 0.361Â±0.031 0.353Â±0.030 0.376Â±0.033</cell><cell>0.452Â±0.071 0.490Â±0.059</cell></row><row><cell></cell><cell></cell><cell>C4</cell><cell cols="3">0.256Â±0.045 0.218Â±0.041 0.193Â±0.039</cell><cell>0.168Â±0.061</cell></row><row><cell>400</cell><cell cols="3">3.7. Identifying New DTIs</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_12"><head>Table 8 :</head><label>8</label><figDesc>Top five new DTIs predicted by our method on dataset for four classes.</figDesc><table><row><cell>Dataset</cell><cell>Rank</cell><cell>Drug</cell><cell cols="2">Target Databases</cell></row><row><cell>Enzyme</cell><cell>1</cell><cell cols="2">D00542 hsa1571</cell><cell>M</cell></row><row><cell></cell><cell>2</cell><cell cols="2">D00423 hsa4860</cell></row><row><cell></cell><cell>3</cell><cell cols="2">D00762 hsa5742</cell></row><row><cell></cell><cell>4</cell><cell cols="2">D00448 hsa5742</cell><cell>C, D</cell></row><row><cell></cell><cell>5</cell><cell cols="2">D00043 hsa1990</cell><cell>M</cell></row><row><cell>Ion Channel</cell><cell>1</cell><cell cols="2">D00799 hsa3782</cell></row><row><cell></cell><cell>2</cell><cell cols="2">D00438 hsa779</cell><cell>C, D, K</cell></row><row><cell></cell><cell>3</cell><cell cols="2">D00552 hsa6331</cell><cell>K</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_13"><head>Table 9 :</head><label>9</label><figDesc>Overall average running time (sec) of different methods on four species.</figDesc><table><row><cell>Method</cell><cell>Script type</cell><cell cols="4">Enzyme Ion Channel GPCR Nuclear receptor</cell></row><row><cell>Our method</cell><cell>MATLAB</cell><cell>476.9</cell><cell>77.4</cell><cell>34.7</cell><cell>3.6</cell></row><row><cell>NRLMF</cell><cell>Python</cell><cell>403.4</cell><cell>52.2</cell><cell>30.6</cell><cell>4.2</cell></row><row><cell>CMF</cell><cell>Python</cell><cell>627.6</cell><cell>135.3</cell><cell>91.4</cell><cell>17.6</cell></row><row><cell>KBMF2K</cell><cell>Python&amp;MATLAB</cell><cell>711.2</cell><cell>175.4</cell><cell>121.2</cell><cell>8.5</cell></row><row><cell>WNN-GIP</cell><cell>Python</cell><cell>40.4</cell><cell>3.8</cell><cell>2.6</cell><cell>0.3</cell></row><row><cell>NetLapRLS</cell><cell>Python</cell><cell>17.6</cell><cell>1.3</cell><cell>0.7</cell><cell>0.1</cell></row><row><cell>BLM-NII</cell><cell>Python</cell><cell>16.6</cell><cell>1.2</cell><cell>0.8</cell><cell>0.1</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>This work is supported by a grant from the National Science Foundation of 470 China (NSFC 61402326), Peiyang Scholar Program of Tianjin University (no. 2016XRG-0009), and the Tianjin Research Program of Application Foundation and Advanced Technology (16JCQNJC00200).</p></div>
			</div>


			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and material</head><p>All DTIs datasets, feature sets, the relevant algorithm and top 500 new DTIs</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M A N U S C R I P T</head><p>the second best performance on Enzyme (AUC: 0.983, AUPR: 0.899) and GPCR (AUC: 0.961, AUPR: 0.821) datasets. These results indicate that the proposed method outperforms existing outstanding approaches on Ion Channel dataset, and is comparable on Enzyme and GPCR datasets. However, our method and other existing tools didn't perform well on Nuclear receptor. The main reason is 375 that the size of Nuclear receptor data set is too small and imbalance data set exacerbates this problem. What's more, the performance of our method (no net) are worse than the method including net features. Comparing with proposed method, the AUPRs of our method (no net) drop 0.226, 0.22, 0.295 and 0.198 on four datasets, respectively. Net features could help model improve the prediction 380 performance of DTIs. The average AUC and AUPR of our method are shown in Figure <ref type="figure">11</ref> and Figure <ref type="figure">12</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6.">Evaluation on Pair-Input Computational Prediction</head><p>Many computational prediction methods operated on object pairs, have been used in many areas of biology and chemistry <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b8">10]</ref>. Park and Marcotte 385 <ref type="bibr" target="#b19">[21]</ref> gave the paired nature of input for pair-input methods, and evaluate their predictive performance on different classes of test pairs. Based on evaluation method <ref type="bibr" target="#b19">[21,</ref><ref type="bibr" target="#b24">25]</ref> C4, drugs and targets of test set are both absence from training set. We utilize 5-fold cross validation on datasets, as shown in Table <ref type="table">7</ref>.</p><p>Although the performance of prediction is down in class C2, C3 and C4 on four datasets by a large margin, the performance (AUCs) of prediction is still 395 good but not significantly. In C2, C3 and C4, values of AUC fall gently by 0.048, 0.106 and 0.170 on average. Because of imbalanced datasets, values of AUPR fall sharply by 0.174, 0.431 and 0.617 on average. Tests of C2, C3 and C4 are only used to evaluate the performance of pair-input computational prediction.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A C C E P T E D M A N U S C R I P T</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Fast decorrelated neural network ensembles 480 with random weights</title>
		<author>
			<persName><forename type="first">M</forename><surname>Alhamdoosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Information Sciences</title>
		<imprint>
			<biblScope unit="volume">264</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="104" to="117" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Modelling the transcription factor dnabinding affinity using genome-wide chip-based data</title>
		<author>
			<persName><forename type="first">M</forename><surname>Alhamdoosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">bioRxiv</title>
		<imprint>
			<biblScope unit="page" from="1" to="20" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Supervised prediction of drug-target in-485 teractions using bipartite local models</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bleakley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamanishi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="2397" to="2403" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">A tutorial on support vector machines for pattern recognition</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J C</forename><surname>Burges</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Data Mining and Knowledge Discovery</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="273" to="297" />
			<date type="published" when="1995">1998. 1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Computational prediction of drug target interactions using chemical, biological, and network features</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Tan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Informatics</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="669" to="681" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Large-scale prediction of drug-target inter-495 actions using protein sequences and drug topological structures</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">S</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Analytica Chimica Acta</title>
		<imprint>
			<biblScope unit="volume">752</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">A library for support vector machines</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><surname>Libsvm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACM Trans Intell Syst Technol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="389" to="396" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Information theory of quantum entanglement and 500 measurement</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Cerf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Adami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physica D Nonlinear Phenomena</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="62" to="81" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Predicting protein-protein interactions via multivariate mutual information of protein sequences</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Guo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="398" to="410" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Chembl: a large-scale bioactivity 505 database for drug discovery</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gaulton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Bellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Bento</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">DI</biblScope>
			<biblScope unit="page" from="1100" to="D1107" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Predicting drug-target interactions from chemical and genomic kernels using bayesian matrix factorization</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gnen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="2304" to="2310" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Supertarget and matador: resources for exploring drug-target relationships</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gnther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dunkel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="919" to="922" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Gene selection for cancer classification using support vector machines</title>
		<author>
			<persName><forename type="first">I</forename><surname>Guyon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barnhill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vapnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Machine Learning</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page">2002</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Supertarget goes quantitative: update on drug-target interactions</title>
		<author>
			<persName><forename type="first">N</forename><surname>Hecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Eichborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">D1</biblScope>
			<biblScope unit="page" from="1113" to="1117" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">From genomics to chemical genomics: 520 new developments in kegg</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kanehisa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hattori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">Suppl 1</biblScope>
			<biblScope unit="page" from="354" to="357" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Drugbank 4.0: shedding new light on drug metabolism</title>
		<author>
			<persName><forename type="first">V</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Knox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Djoumbou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">D1</biblScope>
			<biblScope unit="page" from="1091" to="1097" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Neighborhood regularized logistic matrix 525 factorization for drug-target interaction prediction</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Miao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Plos Computational Biology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="7762" to="7773" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Drug-target interaction prediction by learning from local information and neighbors</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Kwoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="238" to="245" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Drug-target interaction prediction from pssm based evolutionary information</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Mousavian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khakabimamaghani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kavousi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacological and Toxicological Methods</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="42" to="51" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">A flaw in the typical evaluation scheme for pair-input computational predictions</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Edward</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Method</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">2012</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Predicting drug-target interactions with multi-information fusion</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Q</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Journal of Biomedical and Health Informatics</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="561" to="572" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Brenda in 2013: integrated 540 reactions, kinetic data, enzyme function data, improved disease classification: new options and contents in brenda</title>
		<author>
			<persName><forename type="first">I</forename><surname>Schomburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Placzek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="issue">D1</biblScope>
			<biblScope unit="page" from="764" to="772" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title/>
		<author>
			<persName><surname>A C C E P T E D M A N U S C R I P T</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Predicting protein-protein interactions based only on sequences information</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">545</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="4337" to="4341" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Toward more realistic drug-target interaction predictions</title>
		<author>
			<persName><forename type="first">P</forename><surname>Tapio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Antti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Briefings in Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="325" to="337" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Predicting drug-target interactions for new drug compounds using a weighted nearest neighbor profile</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Van</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Marchiori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Plos One</title>
		<imprint>
			<biblScope unit="volume">550</biblScope>
			<biblScope unit="issue">6</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Gaussian interaction profile kernels for predicting drug-target interaction</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Van</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Nabuurs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Marchiori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="3036" to="3043" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Anfis-based fuzzy systems for 555 searching dna-protein binding sites</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alhamdoosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pedrycz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">bioRxiv</title>
		<imprint>
			<biblScope unit="page" from="1" to="35" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Stochastic configuration networks ensemble with heterogeneous features for large-scale data analytics</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Cui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Information Sciences</title>
		<imprint>
			<biblScope unit="volume">417</biblScope>
			<biblScope unit="page" from="55" to="71" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Research article: Kernel-based 560 data fusion improves the drug-protein interaction prediction</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">Y</forename><surname>Deng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Computational Biology and Chemistry</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="353" to="362" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Local-dpp: An improved dna-binding protein prediction method by exploring local evolutionary information</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Information Sciences</title>
		<imprint>
			<biblScope unit="volume">384</biblScope>
			<biblScope unit="page" from="135" to="144" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Systems Biology</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">Suppl 2</biblScope>
			<biblScope unit="page" from="6" to="17" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Feature selection and analysis on correlated gas sensor data with recursive feature elimination</title>
		<author>
			<persName><forename type="first">K</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Sensors and Actuators B: 570 Chemical</title>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="353" to="363" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
